SE
Suresh Eknath Jangale
About Suresh Eknath Jangale
Data last updated:
Suresh Eknath Jangale is a Designated Partner at Cranberries Pharmaceuticals Llp (since 2024). The company operates in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cranberries Pharmaceuticals Llp ACG-0487 | Designated Partner | 13 Mar 2024 | 2024 | Active |
Board colleagues of Suresh Eknath Jangale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Vaijanathrao Gavali | 10548619 | Cranberries Pharmaceuticals Llp | Designated Partner |
| Krishna Ansiram Yadav | 09305547 | Cranberries Pharmaceuticals Llp | Designated Partner |
| Mahesh Ramnath Phalke | 10548620 | Cranberries Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Eknath Jangale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Eknath Jangale
Suresh Eknath Jangale currently holds 1 directorship: Cranberries Pharmaceuticals Llp (Designated Partner, since 13 Mar 2024).
Suresh Eknath Jangale was first appointed on 13 Mar 2024 as Designated Partner at Cranberries Pharmaceuticals Llp.
The current boards of Suresh Eknath Jangale's companies include Anil Vaijanathrao Gavali (Cranberries Pharmaceuticals Llp), Krishna Ansiram Yadav (Cranberries Pharmaceuticals Llp), Mahesh Ramnath Phalke (Cranberries Pharmaceuticals Llp).